SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-412231
Filing Date
2014-11-14
Accepted
2014-11-14 09:03:26
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d780020d10q.htm 10-Q 384052
2 EX-31.1 d780020dex311.htm EX-31.1 6546
3 EX-31.2 d780020dex312.htm EX-31.2 6899
4 EX-32.1 d780020dex321.htm EX-32.1 4392
5 EX-32.2 d780020dex322.htm EX-32.2 4347
  Complete submission text file 0001193125-14-412231.txt   3232961

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flxn-20140930.xml EX-101.INS 378917
7 XBRL TAXONOMY EXTENSION SCHEMA flxn-20140930.xsd EX-101.SCH 31659
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20140930_cal.xml EX-101.CAL 54239
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20140930_def.xml EX-101.DEF 110675
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20140930_lab.xml EX-101.LAB 287674
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20140930_pre.xml EX-101.PRE 206158
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 141220775
SIC: 2834 Pharmaceutical Preparations